Literature DB >> 7229921

Plasma protein binding and urinary excretion of R- and S-epimers of an arylmalonylamino 1-oxacephem. I: In humans.

H Yamada, T Ichihashi, K Hirano, H Kinoshita.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1981        PMID： 7229921     DOI： 10.1002/jps.2600700130

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN： 0022-3549            Impact factor:   3.534


× No keyword cloud information.
  11 in total

Review 1.  Stereoselectivity in clinical pharmacokinetics and drug development.

Authors:  D B Campbell
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1990 Apr-Jun       Impact factor: 2.441

2.  Comparative multiple-dose pharmacokinetics of cefotaxime, moxalactam, and ceftazidime.

Authors:  R Lüthy; J Blaser; A Bonetti; H Simmen; R Wise; W Siegenthaler
Journal:  Antimicrob Agents Chemother       Date:  1981-11       Impact factor: 5.191

3.  Moxalactam kinetics during continuous ambulatory peritoneal dialysis after intraperitoneal administration.

Authors:  T E Jones; R W Milne; Y Mudaliar; L N Sansom
Journal:  Antimicrob Agents Chemother       Date:  1985-08       Impact factor: 5.191

4.  Stereoselective disposition of sulbenicillin in humans.

Authors:  T Itoh; N Watanabe; M Ishida; Y Tsuda; S Koyano; T Tsunoi; H Shimada; H Yamada
Journal:  Antimicrob Agents Chemother       Date:  1998-02       Impact factor: 5.191

5.  Epimerization kinetics of moxalactam in frozen urine and plasma samples.

Authors:  N Hashimoto; T Ichihashi; K Hirano; H Yamada
Journal:  Pharm Res       Date:  1990-04       Impact factor: 4.200

6.  Stereoselective renal tubular secretion of carbenicillin.

Authors:  T Itoh; M Ishida; Y Onuki; Y Tsuda; H Shimada; H Yamada
Journal:  Antimicrob Agents Chemother       Date:  1993-11       Impact factor: 5.191

7.  Human pharmacokinetics and antimicrobial activities of the temocillin epimers.

Authors:  E A Guest; R Horton; G Mellows; B Slocombe; A J Swaisland; T C Tasker; A R White
Journal:  Drugs       Date:  1985       Impact factor: 9.546

Review 8.  Clinical pharmacokinetics of the third generation cephalosporins.

Authors:  L Balant; P Dayer; R Auckenthaler
Journal:  Clin Pharmacokinet       Date:  1985 Mar-Apr       Impact factor: 6.447

Review 9.  Moxalactam (latamoxef). A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.

Authors:  A A Carmine; R N Brogden; R C Heel; J A Romankiewicz; T M Speight; G S Avery
Journal:  Drugs       Date:  1983-10       Impact factor: 9.546

10.  Determination of moxalactam in human body fluids by liquid chromatographic and microbiological methods.

Authors:  D J Miner; D L Coleman; A M Shepherd; T C Hardin
Journal:  Antimicrob Agents Chemother       Date:  1981-08       Impact factor: 5.191
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.